Physician

Walter Jefferies Doty, M.D.

According to 2025 Medicare claims, Walter Doty, M.D. (NPI: 1518160605) practices pulmonary disease in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is PULMONARY ASSOCIATES, PA (NPI: 1912987785; TIN: 63-0830848) and primary practice location at 36301-4770. Doty is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Doty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,414 traditional Medicare patients, billed 5,705 HCPCS/CPT codes, and received $287,381 in Medicare payments. The top billing code was 99490 (Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month). Part D data shows 234 prescription claims across 56 beneficiaries totaling $162,240 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 14 claims. Open Payments data shows 30 records totaling $922. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $20,896 and ending at $3,079.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	813	3,182	$192,283
2016	1,128	3,871	$255,622
2017	1,177	3,773	$222,140
2018	957	3,251	$197,041
2019	877	2,942	$182,242
2020	692	2,312	$158,689
2021	947	2,959	$184,904
2022	1,033	3,491	$189,434
2023	1,173	4,091	$224,219
2024	1,414	5,705	$287,381

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	145	643	$47,232
2016	217	961	$121,271
2017	277	1,357	$447,451
2018	276	1,442	$506,031
2019	274	1,852	$831,423
2020	281	2,041	$1,132,692
2021	255	1,470	$840,060
2022	168	836	$466,326
2023	113	771	$365,843
2024	56	234	$162,240

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	170	$12,538
2016	15	391	$40,503
2017	44	410	$34,371
2018	24	238	$21,881
2019	20	429	$34,313
2020	23	521	$33,876
2021	21	453	$44,190
2022	11	241	$11,985
2023	N/R	132	$10,586
2024	N/R	14	$1,240

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	597	2,318	$46
94729	Test to examine how well the lungs exchange gases	529	537	$35
94727	Test to determine lung volumes using gas dilution or washout	392	398	$28
94060	Test to measure expiratory airflow and volume changes before and after medication administration	312	314	$24
94010	Test to measure expiratory airflow and volume	317	325	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	600	$13,232
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	353	$635

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$1,240

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$922	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Walter Jefferies Doty, M.D.?

Tedicare shows public-source Medicare data for Walter Jefferies Doty, M.D. (NPI 1518160605), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Walter Jefferies Doty, M.D. have ACO affiliation data?

Walter Jefferies Doty, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Walter Jefferies Doty, M.D.?

Walter Jefferies Doty, M.D. is linked to PULMONARY ASSOCIATES, PA (billing NPI 1912987785) in the available physician profile data.

Does Walter Jefferies Doty, M.D. have Open Payments data?

Walter Jefferies Doty, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.